Matthew Khine MYINT
Our group focuses on understanding breast cancer susceptibility and the development of blood-based tests for the early detection of breast cancer. Our key findings are as follows:
Our group has received funding from the National Medical Research Council (NMRC) of Singapore, the National Cancer Centre Singapore (Centre grant and NCC Research Fund), and the Industry Alignment Fund.
Figure 1: Box-and-whisker plots representing RT-PCR results for four microRNAs. The y-axis depicts log2 fold change. These microRNAs can distinguish between serum samples from breast cancer cases (n = 132) and healthy controls (n = 101) with statistically significant P values (P<1E-8). (Clin Cancer Res. 2013;19:4477-4487
Subscribe to our mailing list to get the updates to your email inbox...
11 Hospital Crescent, Singapore 169610 +65 6436 8000